Shagun Singh

Shagun Singh is an experienced finance professional specializing in equity research within the medical technology sector. As of January 2021, Shagun serves as the Director and Senior Equity Research Analyst at RBC Capital Markets. Prior experience includes roles as a Senior Research Analyst at Wells Fargo Securities from January 2017 to December 2021 and at Sterne Agee CRT from January 2010 to December 2016, both focusing on MedTech equity research. Shagun began a career in equity research at BMO Capital Markets, covering medical technology stocks from January 2005 to December 2009. Shagun holds a Bachelor of Arts in Economics and Foreign Affairs from the University of Virginia and attended The London School of Economics and Political Science for studies related to the European Union in 2004.